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Central arterial systolic blood pressure (SBP) and arterial stiffness are known to be better 22 
predictors of adverse cardiovascular outcomes than brachial SBP. The effect of progressive 23 
high altitude (HA) on these parameters has not been examined.  24 
Ninety healthy adults were included. Central BP and the augmentation index (AI) were 25 
measured at the level of the brachial artery (Uscom BP+ device) at <200m and at 3619m, 26 
4600m and 5140m. The average age of the subjects (70% men) were 32.2±8.7 years. 27 
Compared with central arterial pressures, brachial SBP (+8.1±6.4 mmHg; p<0.0001) and 28 
pulse pressure (+10.9±6.6 mmHg; p<0.0001) were significantly higher and brachial DBP 29 
was lower (-2.8±1.6 mmHg; P<0.0001). Compared <200m, HA led to a significant 30 
increase in brachial and central SBP. Central SBP correlated with AI (r=0.50; 95% CI: 31 
0.41 to 0.58: p<0.0001) and age (r=0.32; 21to 0.41: p<0.001). AI positively correlated with 32 
age (r=0.39; p<0.001) and inversely with subject height (r=-0.22; p<0.0001) weight (r=-33 
0.19; p=0.006) and heart rate (r=-0.49: p<0.0001). There was no relationship between 34 
acute mountain sickness scores (LLS) and AI or central BP. The independent predictors of 35 
central SBP were male sex (coefficient, t 4.7; P<0.0001), age (t=3.6; p=0.004) and AI 36 
(t=7.5; p<0.0001; overall r2 =0.40; p<0.0001). Subject height (t=2.4; p=0.02), age (7.4; 37 
p<0.0001) and heart rate (t=11.4; P<0.0001) were the only independent predictors of AI 38 
(overall r2=0.43; p<0.0001). Central BP and AI significantly increase at HA. This rise was 39 
influenced by subject-related factors and heart rate but not independently by altitude, LLS 40 
or SpO2.   41 
 42 
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Introduction  44 
Cardiovascular death is a leading non cause of non-traumatic deaths in adults at high 45 
altitude (HA).1 Despite this fact, there has been limited research into cardiovascular risk 46 
assessment at HA. 1 HA exposure leads to an increase in resting heart rate, compared with 47 
that at sea level, yet paradoxically, maximal heart rate is reduced.2   The stroke volume rise 48 
noted with exercise at sea level is blunted at HA.2,4 Consequently, whilst resting cardiac 49 
output is higher at HA, versus sea level, at peak exercise it is comparatively lower.2,4,5 50 
These factors along with the notable reduction in arterial oxygen content act to limit peak 51 
exercise capacity and oxygen consumption.2,5 Other reported cardiovascular responses 52 
include an increase in resting brachial artery systolic blood pressure (SBP) and 24hour 53 
arterial blood pressure (BP), which along with the increase in resting heart rate could be 54 
potential implicating factors in the increased cardiovascular risk.6-9    55 
The effects of HA on central arterial haemodynamics, such as central arterial BP and large 56 
artery stiffness, are far less well understood and have been barely reported. Central arterial 57 
BP and large artery stiffness are known to be more powerful predictors of adverse 58 
cardiovascular outcomes, including stroke and cardiovascular death than brachial artery BP 59 
as they more closely reflect the haemodynamic loading of vital central organs such as the 60 
heart, brain and kidneys.10.11 Brachial artery BP does not reliably reflect central BP due to 61 
the effects of peripheral amplification which is highly variable between individuals.10,11      62 
 Unfortunately, the accurate non-invasive assessment of central BP and large artery 63 
stiffness has been traditionally very difficult. It had required the need for either arterial 64 
catheterisation or less portable and expensive non-invasive equipment limiting its research 65 
utility at HA, explaining the paucity of published research at genuine terrestrial HA.5.7  66 
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In the only study to investigate the influence of terrestrial HA on both large arterial 67 
stiffness and central BP Parati et al observed a significant increase in both central SBP and 68 
the arterial augmentation index (AI, marker of arterial stiffness) in untreated subjects 69 
travelling to HA.7 However, the altitude gain was very rapid (4559m within 28 hours of 70 
ascent) and only a single altitude was studied. Nevertheless, their findings are potentially 71 
important given the huge numbers exposed to HA worldwide.1,2  72 
The Uscom BP+ is a novel device which is able to estimate central blood pressure 73 
using a simple oscillometric BP cuff on the upper arm.12 It has shown excellent agreement 74 
with catheter based assessments of central BP and gold standard measures of arterial 75 
stiffness.1315 It utilises pulse wave analysis to assess the AI which reflects the enhancement 76 
(augmentation) of central aortic systolic pressure by reflected arterial pulse waves. It has 77 
the advantage over several competing devices. It is highly portable and only requires the 78 
use of an upper arm cuff therefore avoiding the need to assess either the radial or digital 79 
pulse where the signal to noise ratio may be less favourable.   80 
In this study we sought to utilise this available technology to investigate, for the 81 
first time the effects of a step-wise increasing terrestrial HA on both central BP and AI 82 
during a trek to >5000m.  83 
  84 
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Methods 85 
Study design and participants 86 
Ninety healthy British Military servicemen aged >18years were included. The subjects 87 
were assessed at near sea level (<200m) and during progressive ascent in the Dhaulagiri 88 
region in the Himalayas in March/April 2016. Health status was confirmed following a 89 
detailed baseline questionnaire. All subjects were assessed to be medically fit for a high 90 
altitude venture by their general practitioner. Key exclusion criteria included a history of 91 
hypertension and/ or atrial fibrillation. All participants were low altitude dwellers and none 92 
had prior exposure to >1400m terrestrial altitude in the four weeks prior to this study. The 93 
subjects were studied consecutively in groups of 8-10 individuals with a two day stagger 94 
between successive groups.  HA related symptoms were assessed using the Lake Louis 95 
Scoring System (LLS).16,17  96 
 97 
High Altitude Ascent and descent profile 98 
The subjects flew from the UK to Kathmandu (1400m day 1-3) where they underwent a 99 
short period of local acclimatisation at 1400m. From there they travelled by a staged road 100 
move to Darbang (1030m) then on foot with loads of up to 12kg over the ensuing 11 days 101 
to HA of 5140m (after passing over French pas at 5360m) (figure 1). Thereafter, they 102 
descended on foot and then by road back to Kathmandu. Research assessments were 103 
performed at sea level and at static research camps at 3619m, 4600m and 5140m during 104 
ascent.  105 
 106 
Physiological assessments and central blood pressure measurement 107 
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Oxygen saturations (SpO2) were measured using a Nonin Onyx (Nonin Medical Inc, 108 
Plymouth, Minnesota) pulse oximeter.  Blood pressure and arterial stiffness assessments 109 
were obtained at the same time using an Uscom BP+ device (Uscom, Sydney, NSW, 110 
Australia as previously reported.13-15 The upper arm cuff was attached to the dominant arm 111 
of seated subjects. All subjects were rested for at least five minutes prior to BP assessment 112 
and they were not permitted to drink caffeine or smoke for at least three hours and alcohol 113 
for >10 hours prior to BP measurements.18  The subjects were advised not to speak during 114 
the recordings. The BP+ device measures both central and peripheral BP (mmHg) using 115 
supra systolic oscillometry.  Following an initial inflation-deflation the cuff is re-inflated to 116 
approximately >30mm Hg above the recorded suprasystolic pressure for 10 seconds, 117 
during which suprasystolic BP and pulse wave assessments are recorded via the arm cuff.  118 
All recordings were stored on a mini SD card within the device and later exported for data 119 
analysis.  Only readings with a signal-to-noise ratio of ≥6 was were included and tests with 120 
a ratio of <6 were repeated.  121 
The BP+ calculates a number of additional haemodynamic indices that were of 122 
interest to this study, including the AI. Its quoted AI is the arterial augmentation pressure 123 
(difference between the second and first systolic peaks of the central pressure waveform) 124 
expressed as a percentage of the pulse pressure and it is an indirect measure of large 125 
arterial stiffness. Further parameters that we were specifically interested in for this study 126 
were the time to systolic wave Reflection (TR) and the suprasystolic pulse pressure 127 
variation (ssPPV). The reflected Wave Transit Time is an indirect measure of pulse wave 128 
velocity and large arterial stiffness. The ssPPV is a novel measure of fluid responsiveness 129 
and is heavily influenced by respiratory variation and left ventricular stroke volume, both 130 
of which can be affected at HA.19-21   The BP+ calculates the ssPPV as the difference 131 
 7
between maximum and minimum pulse pressures divided by the average pulse pressure 132 
over the 10 second rhythm strip.  133 
 134 
Ethics 135 
Participation was entirely voluntary and all participants underwent detailed written 136 
informed consent.  The study was approved by the Ministry of Defence Research and 137 
Medical Ethics Committee (MODREC) and was conducted according to the standards of 138 
the declaration of Helsinki.  139 
 140 
Statistical analysis  141 
Data were analysed using GraphPad InStat version 3.05 and with all graphical figures 142 
presented using GraphPad Prism version 4.00 for Windows (GraphPad Software, San 143 
Diego, CA, USA). Sample size calculations were performed using a proprietary 144 
determined sample- size calculator using (GraphPad StatMate version 2.00 for Windows). 145 
The Kolmogorov-Smirnov test was undertaken to assess normality of all continuous data 146 
and all continuous data are presented as mean ± standard deviations. Comparison of 147 
unpaired data was performed using an unpaired T test or the Mann-Whitney Test for 148 
parametric and non-parametric data respectively and with a paired t test and Wilcoxon 149 
matched pairs test for equivalent paired data.  Continuous data from >3 groups were 150 
compared using a one-way Analysis of Variance (ANOVA) with either Tukey post-hoc 151 
tests or a Kruskal-Wallis test with Dunn post-test  for parametric and  non-parametric data 152 
respectively. Correlations were performed using Pearson and Spearman rank correlation 153 
(±95% confidence interval, CI) for parametric and non-parametric data respectively.  A 154 
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two tailed P value <0.05 was considered statistically significant for all comparisons. All 155 
univariate predictors of central arterial systolic blood pressure were entered into a multiple 156 
linear regression analysis model in order to identify its independent predictors. A two 157 
tailed P value <0.05 was considered statistically significant for all comparisons.  158 
Sample size calculations  159 
Parati et al studied 44 subjects who travelled form sea level to 4559m within 29 hours.8 160 
From this group there were 22 subjects who were randomised not to receive prophylactic 161 
medication to prevent acute mountain sickness. In this group they observed a non-162 
significant increase in central systolic blood pressure from 103.7±10.7 to 108.8±8.0 mmHg 163 
from sea level to that after 48h at HA. The AI significantly increased at HA versus sea 164 
level. Based on this data and the average standard deviation of their central BP readings, 165 
we calculated that a sample size of at least 60 subjects would have >80% power to detect a >5 166 
mmHg change in central SBP and a >7% change in AI at HA at a significance level (alpha) 167 
of 0.05 (two-tailed). 168 
 169 
Results 170 
Ninety subjects were included. The average age of the subjects were 32.2±8.7 years with 171 
70% being male. Heart rate and LLS increased and SpO2 fell at HA compared with sea 172 
level (table 1). 173 
Overall brachial arterial SBP (+8.1±6.4 mmHg; p<0.0001) and pulse pressure 174 
(+10.9±6.6 mmHg; p<0.0001) were significantly greater than that observed centrally.  175 
Conversely the brachial artery DBP was lower (-2.8±1.6 mmHg; P<0.0001) than the 176 
equivalent central readings.   177 
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 Compared with baseline sea level values there was a significant increase in both 178 
brachial and central SBP and in brachial but not central arterial pulse pressure at HA (table 179 
2). The highest increase in both brachial and central SBP was between sea level and 4619m 180 
(+6.1±13.30 and +7.1±5.5 mmHg respectively) (table 2; figure 2).  181 
 The AI and ssPPV both increased at HA whereas the reflected wave transit time 182 
and systolic ejection period decreased versus sea level (table 2; figure 3). Adjusting the AI 183 
to an average heart rate of 75 per minute (AI@75) did not alter the findings.  184 
There were significant correlations between central SBP and both AI (r=0.50; 0.41 185 
to 0.58: p<0.0001) and age (r=0.32; 21to 0.41: p<0.001). Other independent, albeit weak 186 
predictors, of central SBP were SpO2 (r=-0.14 -0.25 to -0.05: p=0.02),  heart rate (r=-0.16; 187 
-0.27 to -0.05: p=.003) male sex (r =0.15; 046 to 0.26: p=0.004) ethnicity (r=0.15; 0.04 to 188 
0.25: p=0.007) smoking status (r=0.18; -0.28 to -0.07; p=0.001) and altitude (r=0.10; 189 
p=0.05).  AI positively correlated with age (r=0.39; p<0.001) and inversely with subject 190 
height (r-0.22; p<0.0001) weight (r-0.19; p=0.006), and heart rate (-0.49: p<0.0001). There 191 
was no relationship between LLS and either AI or central BP.  192 
Multivariate analysis was performed to assess the independent predictors of central 193 
systolic BP. Only the univariate predictors were included in the model. The independent 194 
predictors of central SBP were male sex (coefficient, t 4.7; P<0.0001), age (t 3.6; p=0.004) 195 
and AI (t 7.5; p<0.0001; overall r2 =0.40; p<0.0001). If AI was removed from the model 196 
(overall r2=0.29; p<0.0001) then the independent predictors of central systolic BP were 197 
age, heart rate and smoking history.  Subject height (coefficient 2.4; p=0.02), age (7.4; 198 
p<0.0001) and heart rate (11.4; P<0.0001) were the only independent predictors of AI 199 
(overall r2=0.43; p<0.0001). The order of the trekking groups did not influence the findings 200 
when included in the multivariate analysis.  201 
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Discussion 203 
To the author’s knowledge, this is the first study to assess the effects of stepwise increasing 204 
terrestrial HA on arterial stiffness and central BP over a conventional and progressive HA 205 
trek. We found that HA exposure led to a significant increase in central SBP and AI. 206 
Neither altitude nor the SpO2 were independent predictors of AI and central SBP. Heart 207 
rate was a significant determinant of both AI and central BP.  208 
 HA exposure leads to a wide range of complex effects on both the pulmonary and 209 
systolic circulation which have been well described.2,4,5,22 Hypobaric hypoxia leads to 210 
widespread sympathetic activation leading to an increase in resting heart rate .23-25  The 211 
reported effects on BP are variable and are highly dependent on the degree of hypoxia and 212 
speed and duration of exposure.  Furthermore, the type of hypoxic environment may be a 213 
major confounder.26 Several previously published studies have used simulated hypoxia 214 
(using either a normobaric or hypobaric chamber) in an attempt to replicate the degree of 215 
hypoxia observed at genuine HA.4,22,25,26 However, simulated hypoxia does not reproduce 216 
the environmental and geographical effects genuine terrestrial HA such as the cold or the 217 
exercise burden. The reported literature has tended to focus on the effects of HA on 218 
brachial artery BP and largely following a relatively short period brief (<6 hours) of 219 
simulated hypoxia.22,26 Available data at terrestrial HA has shown that HA exposure 220 
typically leads to an increase in both resting systolic and 24 hour blood pressure which 221 
may be more pronounced in those with background hypertension.9 The effects of HA on 222 
central BP and arterial stiffness have been barely examined at HA, yet they are well 223 
recognised to be better predictors of cardiovascular risk than brachial BP.10,11 Given the 224 
vast numbers of patients with known hypertension and cardiovascular disease who undergo 225 
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recreational HA exposure annually the ability to better define cardiovascular risk in these 226 
individuals would be important. This has added importance given that cardiovascular death 227 
is a leading cause of non-traumatic death at HA.1 An improved understanding of the effects 228 
of HA on central BP and other non-invasive measures of cardiovascular risk such as 229 
arterial stiffness might allow for tailored medical therapy at HA to reduce the 230 
cardiovascular risk to individuals. We observed a significant increase in brachial but not 231 
central pulse pressure suggesting differences in BP behaviour in the peripheral versus the 232 
central circulation. Indeed whilst the brachial SBP was higher than that observed centrally 233 
the increase  in central SBP was greater and was significant across all three altitudes 234 
studied (table 2).  235 
There has only been one previous study to investigate the effects of HA on 236 
measures of both arterial stiffness and central BP at terrestrial altitude. Parati et al studied 237 
44 subjects who were randomised to placebo or to oral acetazolamide prior to and during 238 
HA exposure.8 Following sea level assessment the subjects ascended to 4559m within 28 239 
hours by road to 1130m, then cable car to 3647m before completing the rest of the ascent 240 
on foot. Measurements at HA were obtained within 4-6 hours of arrival at 4559m and 241 
again after two days at this altitude. They observed a non-significant increase in both 242 
central and peripheral SBP but an even greater and significant increase in DBP.  AI@75 243 
significantly increased from Sea level to HA. However, whereas the SBP continued to 244 
increase from 4-6 hours to two days at HA there was no further increase in the AI@75 245 
beyond the early increase. In our study we noted a similar sized increase in both brachial 246 
and central SBP to that in this previous study and the significance in our current study 247 
likely relate to our much larger sample size. Our data would seem to suggest that the 248 
increase in heart rate is a significant independent predictor of the increase in AI at HA 249 
which was not directly related to either the SpO2 or altitude. The observed increase in heart 250 
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rate, AI, brachial and central SBP would strongly suggest that these increases relate to 251 
sustained sympathetic activation at HA as has been well described rather than a genuine 252 
increase in large artery stiffness.23  253 
 In one of the only previously published studies to assess the effects of HA on 254 
arterial stiffness and brachial BP during a conventional trek Rhodes et al studied 17 255 
subjects over an ascent from 80m to 4770m over 11 days.6 They found that HA led to a 256 
transient increase in large artery stiffness index (using finger photoplethysmography) noted 257 
at day four at 3450 m before returning to baseline levels. A significant rise in both systolic 258 
and diastolic BP were observed at 3450m and the increase was sustained throughout the 259 
HA exposure.6 Interestingly, they observed that the increase in BP was not related to 260 
changes in arterial stiffness nor was there a link between the increase in arterial tone and 261 
the presence of AMS. We did not identify a relationship between LLS, SpO2 and either AI, 262 
which is an indirect measure of large artery stiffness and central systolic BP at HA.   263 
 Consistent with previous research we found that the AI related to the 264 
subjects age and inversely correlated with height and heart rate.27,28 This is explained by 265 
the fact that the time of the reflected wave is related to the dimensions of the body and 266 
heart rate. In shorter individuals, a reduced return time for reflected waves leads to an 267 
increase in central pressure augmentation.27 As a result of the noted influence of heart rate 268 
on AI it has been suggested that AI should be adjusted for the effects of heart rate and this 269 
has traditionally been to an average of 75 per minute (AI@75).29 Adjusting the AI@75 to 270 
account for heart rate did not alter our findings. It has also been more recently suggested 271 
that adjusting for heart rate on multivariate analysis of AI is more appropriate and this has 272 
been additionally done in our analysis.30 Our data has shown that heart rate was the 273 
independent variable with the greatest impact on AI. Indeed augmentation of central BP is 274 
influenced by heart rate and therefore the duration of systole and shifting the reflected 275 
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arterial wave to diastole and reducing the time to wave reflection as has been observed in 276 
our study.29 Therefore it is reasonable to assume that the increase in AI at HA is largely 277 
related to the associated increase in heart rate leading to a rise in arterial augmentation and 278 
central BP rather than actual changes in large artery stiffness over only 14 days HA 279 
exposure.  280 
In this study we were also interested in the effects of HA on the ssPPV. This is a 281 
measure of the variation in the pulse pressure averaged over the 10 second arterial 282 
waveform recording using the BP+ device.  The beat to beat variation in pulse pressure is 283 
known be influenced by a number of factors including left ventricular preload, stroke 284 
volume and ventilation, which are all known to be affected at HA.22 Clinically, probably 285 
the most widespread use of ssPPV has been to assess fluid responsiveness in mechanically 286 
ventilated patients intra-operatively and on intensive care.20,21 During inspiration negative 287 
intrathoracic pressure leads to an increase in venous return and ultimately an increase in 288 
ventricular filling. Its effect on left ventricular stroke volume is influenced by hydration 289 
and intravascular filling, which is dependent on the relative position on the Frank-Starling 290 
curve.19HA-related hypoxia has been shown to affect both right and left ventricular stroke 291 
volume with variable effects on ventricular filling.4.22.25 The mechanisms to explain these 292 
changes are complex and include the known hypoxia mediated pulmonary vasoconstriction 293 
leading to an increase in pulmonary artery systolic pressure and right ventricular afterload.5 294 
HA acclimatisation is known to lead to relative dehydration and hypoxia-mediated 295 
hyperventilation all of which may affect biventriuclar ventricular  stroke volume. Whilst 296 
the ssPPV cannot be used in isolation serial measurements can be used to assess filling and 297 
fluid responsiveness. In our study the ssPPV was very susceptible to the effects of HA 298 
exposure but was not related to LLS. HA led to a marked increase in the ssPPV, despite no 299 
significant increase in the central arterial pulse pressure.  300 
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This study has a number of limitations that require acknowledgement. The subjects 301 
were studied in groups two days apart. This was done to accommodate the large sample 302 
size of the study and ensure excellent reproducibility of the measures and ensure that 303 
subject BP measurements were conducted robustly at each individual research station by 304 
trained researchers. The environmental factors, such as temperature and barometric 305 
pressure would not have been identical for the study groups at the time of their data 306 
collection which could have potentially influenced the findings. However, we did not 307 
observe any significant influence of the trekking group order of study on either AI or 308 
central systolic blood pressure. Unfortunately, we did not measure hormonal markers of 309 
sympathetic activation, such as circulating catecholamines, to better investigate the 310 
mechanism for the increase in SBP and AI, however, we did note that the increases did not 311 
relate to the degree of hypoxia (SpO2) or LLS. 312 
 313 
In conclusion in this study we found that HA exposure led to an increase in brachial and 314 
central SBP and a rise in AI compared with near sea level baseline levels. The increase in 315 
central SBP and AI was not related to the degree of hypoxia and SpO2 at HA nor to LLS. 316 
The observed changes likely relate to increased sympathetic activation rather than any 317 
genuine change in large artery stiffness.  318 
 319 
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What is known about the topic?  329 
●  HA exposure leads to an increase in heart rate and there is evidence from a single study 330 
of rapid largely cable car ascent to 4559m that it leads to an increase in central SBP and 331 
arterial AI.  332 
 333 
What this study adds?  334 
●  This is the first study to examine the effects of stepwise increasing terrestrial HA on 335 
arterial stiffness and central BP over a conventional and progressive HA trek to 336 
>5000m. 337 
• We have discovered that the HA exposure led to a significant increase in central SBP 338 
and AI.  339 
• Neither altitude nor the SpO2 were independent predictors of AI and central SBP. 340 
• The increase in AI related to the increase in heart rate at HA and did not reflect a 341 
genuine change in large artery stiffness.  342 
  343 
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Legends for Figures 438 
 439 
Figure 1Ascent Profile the altitude and timing of data collection  440 
Figure 2 Changes in systolic blood pressure with HA exposure. Symbol* denotes 441 
significant difference vs baseline level   442 
Figure 3 Change in Augmentation Index with high altitude 443 
Table 1: Baseline Demographics  
Demographic Result  
Age, years (range)  32.2±8.7 (18-56) 
Males n, % 63 (70%) 
Height, cm 173.5±9.1  
weight 73.4±12.3 
Body mass index kg/m2 24.38±2.7 
Ethnicity, % 
- Caucasian  
- Nepalese  
- South Asian 
 
87.8% 
11.1% 
11.1% 
Smoking status (N, %) 
- Current  
- Ex  
- Never 
 
9.3% 
12.3% 
78.4% 
 
Table 2 Effect of high altitude on measured vascular parameters including central blood 
pressure and augmentation index 
Parameter Sea level 3619m 4600m 5140m P value 
Heart rate 65.2±12.8 69.6±11.8 77.3±15.3 78.2±13.6 <0.0001abc 
Oxygen Saturations 97.7±1.4† 91.9±3.4 82.8±6.3 80.4±5.3 <0.0001abc 
Lake louis Scores 0.23 (0.64) 1.1 (1.9) 1.4 (1.6) 1.3 (1.4) <0.0001abc 
Brachial artery  
systolic BP 
132.8±14.0 136.9±13.4 138.8±13.3 138.6±13.9 0.04bc 
Brachial artery 
diastolic BP 
81.8±11.7 84.7±9.4 83.7±9.8 83.9±9.7 0.28 
Mean brachial 
arterial BP 
99.3±12.9 102.0±9.9 102.1±9.9 102.2±9.8 0.23 
Brachial artery 
Pulse pressure 
51.6±11.3 52.1±9.7 55.5±10.9 54.7±11.3 0.02b 
Central systolic BP 124.7±14.8 130.1±14.2 131.4±15.4 129.4±14.3 0.02abc 
Central arterial 
diastolic  BP 
84.0±11.6 87.5±9.6 86.8±9.6 87.3±9.5 0.09 
Central artery pulse 
pressure 
40.7±9.5 42.6±9.6 44.6±13.4 42.1±9.9 0.26 
Augmentation  
index, % 
55.3±34.9 71.1±34.1 61.8±36.7 56.6±32.7 0.001b 
Reflected wave 
transit time, s 
0.16±0.02 0.16±0.02 0.14±0.02 0.14±0.01 <0.0001bc 
Systolic ejection 
period, s 
0.30±0.03 0.31±0.02 0.29±0.03 0.28±0.02 <0.0001bc 
Supra Systolic 
pulse pressure 
variation 
0.23±0.13 0.28±0.15 0.37±0.20 0.34±0.19 <0.0001abc 
BP, blood pressure; results of post hoc tests vs baseline sea level, a 3880m, b 4400m, c 5140m 
 



